Your browser doesn't support javascript.
loading
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.
Kolossváry, Márton; deFilippi, Chris; McCallum, Sara; Fitch, Kathleen V; Diggs, Marissa R; Fulda, Evelynne S; Ribaudo, Heather J; Fichtenbaum, Carl J; Aberg, Judith A; Malvestutto, Carlos D; Currier, Judith S; Casado, Jose L; Gutiérrez, Félix; Sereti, Irini; Douglas, Pamela S; Zanni, Markella V; Grinspoon, Steven K.
Affiliation
  • Kolossváry M; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • deFilippi C; Inova Heart and Vascular Institute, Falls Church, VA, 22042, USA.
  • McCallum S; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Fitch KV; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Diggs MR; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Fulda ES; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Aberg JA; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Malvestutto CD; Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Currier JS; Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
  • Casado JL; Division of Infectious Diseases, Ramon y Cajal Health Research Institute (IRyCIS), University Hospital Ramon y Cajal, Madrid, Spain.
  • Gutiérrez F; Division of Infectious Diseases, Hospital General Universitario de Elche and University Miguel Hernández, Alicante, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • Sereti I; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, 27708, USA.
  • Zanni MV; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Grinspoon SK; Metabolism Unit, Massachusetts General Hospital, Boston, MA, 02114, USA. Electronic address: sgrinspoon@mgh.harvard.edu.
EBioMedicine ; 90: 104538, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36966617

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: EBioMedicine Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: EBioMedicine Year: 2023 Type: Article Affiliation country: United States